Report updated May 20, 2026
PMcardio for Individuals
For healthcare professionals including emergency physicians, general practitioners, nurses, paramedics, and cardiologists.
PMcardio for Individuals is a challenged medical app that is free with in-app purchases. With a 4.3/5 rating from 803 reviews, it faces significant user friction. Users particularly appreciate advanced ai diagnostic capabilities provide actionable insights for medical professionals during clinical practice, though geographic access restrictions prevent users in specific regions from utilizing the diagnostic service remains a common concern.
What is PMcardio for Individuals?
PMcardio is a mobile AI assistant for 12-lead ECG interpretation, designed for healthcare professionals to use on iOS and Android.
Clinicians hire the app for rapid, automated diagnostic support on ECG images, serving as a second opinion in high-pressure emergency workflows.
Current Momentum
v3.11 · 2d ago
Active- Launched LVsense ejection fraction module.
- Added clinical calculators for SCORE2.
- Improved Queen of Hearts score precision.
Active Nemesis
Kardia
By AliveCor
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
Recent User Mood
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
Deep learning model for detecting STEMI and occlusive myocardial infarction patterns.
Visual heatmaps highlighting waveform segments that triggered specific AI diagnostic outputs.
Instant calculation of 12 clinical metrics including heart rate and intervals.
How much does it cost?
- Free plan with 5 ECG analyses per month
- Pro plan with unlimited capacity and advanced explainability
The freemium model uses a low-volume free tier to drive acquisition, with a Pro subscription gate for high-frequency professional workflows.
Who Built It?
Powerful Medical
Equipping healthcare professionals with AI-powered ECG interpretation tools to accelerate cardiovascular diagnosis and emergency care coordination.
Portfolio
2
Apps
What other apps does Powerful Medical make?
Explore the full Powerful Medical report
Portfolio breakdown, audience, momentum, and every app published by Powerful Medical.
What do users think recently?
Low confidence · Latest 60 of 73 total reviews analyzed · Based on 73 reviews. Signal may be noisy.
How did the latest release land?
What is the recent mood?
Recent user voice shows a frustrated sentiment. Users appreciate advanced ai diagnostic capabilities provide actionable insights for medical professionals during clinical practice, but report geographic access restrictions prevent users in specific regions from utilizing the diagnostic service.
What Users Love
What Frustrates Users
What Users Want
How have ratings & review volume moved?
Rating, review sentiment, and total reviews over time, with release markers showing the post-launch impact.
Vertical markers = app releases. Hover any release for the post-release impact delta.
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for PMcardio for Individuals?
Where is it available?
Localized markets (1)
How's The Medical Market?
**Pricing Strategy**: Freemium model with a 5-analysis monthly free tier, gating unlimited capacity and explainability features behind a Pro subscription. **Target Audience**: Emergency physicians, general practitioners, nurses, paramedics, and cardiologists. **Chart Performance**: The app maintains a #6 Grossing position in the Medical category across 20+ international markets, though it faces volatility in larger regions like the US (#18 Grossing) and Philippines (#13 Grossing).
How does it evolve in the Medical market?
PMcardio holds a #6 Grossing position in the Medical category across 20+ international markets, but its #18 Grossing rank in the US signals significant friction in the largest professional market. The gap between its diagnostic utility and regional availability limits its ability to capture the full addressable market.
Rank progression
143 active rankings tracked — 30-day window
Which niche is PMcardio for Individuals in?
to interpret ECG readings using artificial intelligence
Explore the full Cardiology Scanners niche
Every app in this space — 1 tracked, the niche's live rankings, and Marlvel's editorial take on the job-to-be-done.
The rivals identified
Nemeses(1)
Kardia is the dominant market leader in ECG interpretation, leveraging a massive user base and deep integration with hardware-backed diagnostic workflows.
Differentiators
- Integrates directly with proprietary mobile ECG hardware to provide clinical-grade diagnostic data for users.
- Offers a closed-loop ecosystem connecting patient-recorded ECGs directly to physician review platforms.
- Maintains a high-frequency release cadence, shipping 7 updates in the last six months to ensure stability.
Head to head
The target app must differentiate by emphasizing its software-only, image-agnostic AI utility to avoid the hardware-dependency barrier that Kardia has successfully institutionalized.
Contenders(2)
PulsePoint dominates the emergency response niche by connecting bystanders to cardiac events in real-time.
Differentiators
- Integrates with local emergency dispatch systems to alert nearby CPR-trained citizens to cardiac arrests.
- Provides a public-safety utility that creates high brand trust and massive user engagement in emergency scenarios.
Doximity serves as the primary professional network for physicians, creating a massive barrier to entry for any clinical tool.
Differentiators
- Functions as a comprehensive professional directory and communication hub for the entire US medical community.
- Aggregates clinical news and career resources, creating a daily-use habit that PMcardio lacks.
Same space(2)
A specialized chronic disease management tool that competes for the attention of healthcare-focused users.
Differentiators
- Provides a gamified, data-driven logging experience specifically tailored for long-term diabetes management and patient compliance.
- Integrates with blood glucose monitors to automate data entry, reducing the manual burden on the user.
An adjacent medical education tool that competes for the same professional screen time as PMcardio.
Differentiators
- Utilizes high-fidelity 3D anatomical modeling to assist in patient education and surgical planning.
- Offers a subscription-based model that provides deep, interactive visual content for medical students and professionals.
New entrants(1)
Rapidly emerging in the healthcare space with a high-velocity release schedule and strong focus on workforce utility.
Differentiators
- Disrupts traditional staffing models by allowing healthcare professionals to claim PRN shifts directly via mobile.
- Maintains a high-frequency update cycle to rapidly iterate on the provider-facing job matching experience.
Compare PMcardio for Individuals against every rival
All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.
The outtake for PMcardio for Individuals
Strengths to defend, gaps to attack
Core Strengths
- Clinical-grade diagnostic capability functions as a B2B distribution barrier
- 19 independent validation studies provide the clinical evidence required for professional adoption
Critical Frictions
- Regional lockout errors block users without warning
- Inconsistent diagnostic accuracy reports erode trust in the AI model
Growth Levers
- Institutional enterprise licensing would allow hospitals to integrate the tool into existing clinical systems
- Expansion into resource-limited markets via tiered pricing
Market Threats
- Kardia's hardware-backed diagnostic ecosystem creates a high switching cost
- Regulatory tightening in the EU and UK limits the addressable market for new AI modules
What are the next best moves?
Audit regional lockout messaging because users report being blocked without warning → reduce churn.
Geographic access restrictions are the top-cited complaint in sentiment analysis.
Trade-off: Pause the LVsense module marketing rollout — fixing the funnel is more critical than new feature awareness.
Ship enterprise licensing portal because institutional requests are the primary growth signal → unlock hospital-wide adoption.
Institutional licensing is the top-requested feature by professional users.
Trade-off: Deprioritize the consumer-facing UI refresh — enterprise revenue has a higher lifetime value per user.
A counter-intuitive read
The app's regional lockout is not just a bug, but a necessary regulatory moat that prevents premature scaling into markets where the AI model lacks certification.
Feature Gaps vs Competitors
- Direct integration with proprietary mobile ECG hardware (available in Kardia but missing here)
Key Takeaways
- The app's diagnostic utility is high, but regional access failures act as a primary churn driver.
- Enterprise licensing is the most viable path to bypass individual subscription friction and regional lockout issues.
- Diagnostic consistency must be the priority over feature expansion to prevent professional user attrition.
PMcardio wins on clinical-grade diagnostic utility, but regional access failures and inconsistent AI outputs threaten its professional retention, so the PM must prioritize enterprise licensing to bypass individual subscription friction.
Where Is It Heading?
Declining
The diagnostic AI market is consolidating around integrated clinical workflows, leaving PMcardio exposed if it cannot resolve regional access friction. The current reliance on individual subscriptions is failing to scale, so the PM must pivot to institutional licensing to secure long-term revenue stability.
Geographic access errors in the latest update drive high churn, which compounds the negative sentiment already visible in professional reviews.
The launch of the LVsense module demonstrates active feature investment, signaling the team is not in maintenance mode despite sentiment headwinds.